Search Results - "Agbana, Preye"
-
1
Ternary Polypeptide Nanoparticles with Improved Encapsulation, Sustained Release, and Enhanced In Vitro Efficacy of Carfilzomib
Published in Pharmaceutical research (01-11-2020)“…Purpose To develop a new nanoparticle formulation for a proteasome inhibitor Carfilzomib (CFZ) to improve its stability and efficacy for future in vivo…”
Get full text
Journal Article -
2
Carfilzomib-Loaded Ternary Polypeptide Nanoparticles Stabilized by Polycationic Complexation
Published in Journal of pharmaceutical sciences (01-03-2024)“…Carfilzomib (CFZ) is a second-generation proteasome inhibitor showing great efficacy in multiple myeloma treatment, yet its clinical applications for other…”
Get more information
Journal Article -
3
Effects of Organic Acids on Drug Release From Ternary Polypeptide Nanoparticles Entrapping Carfilzomib
Published in Journal of pharmaceutical sciences (01-04-2022)“…Carfilzomib (CFZ) is an FDA-approved proteasome inhibitor with antineoplastic properties against various cancers, yet its short blood retention time after…”
Get more information
Journal Article -
4
Compatibility of calcium chloride with milrinone, epinephrine, vasopressin, and heparin via in vitro testing and simulated Y-site administration
Published in American journal of health-system pharmacy (24-01-2023)“…The purpose of this study is to evaluate calcium chloride (CaCl) compatibility with commercially available and extemporaneously compounded milrinone,…”
Get full text
Journal Article